Statin therapy:: a potentially useful peri-operative intervention in patients with cardiovascular disease

被引:38
作者
Biccard, BM
Sear, JW
Foëx, P
机构
[1] Nelson R Mandela Sch Med, Dept Anaesthet, ZA-4013 Congella, South Africa
[2] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Anaesthet, Oxford OX3 9DU, England
关键词
D O I
10.1111/j.1365-2044.2005.04405.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Statin cardiovascular protection is mediated by lipid lowering and pleiotropic effects. The efficacy of statins has been established in non-surgical patients with cardiovascular disease and also more recently in non-surgical patients who sustain an acute coronary event. Peri-operative statin administration has been shown to improve both short-term and long-term cardiac outcome following non-cardiac and coronary bypass graft surgery. This cardioprotection may be independent of peri-operative haemodynamics due to a positive effect on plaque stability. Recommendations for the peri-operative statin administration are suggested. These include indications for peri-operative statin therapy, timing of administration, therapeutic targets, duration of administration, the adverse implications of peri-operative statin withdrawal, safety and cost-effectiveness.
引用
收藏
页码:1106 / 1114
页数:9
相关论文
共 54 条
[1]   Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].
Albert, MA ;
Danielson, E ;
Rifai, N ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70
[2]  
[Anonymous], 2002, JAMA
[3]   Beneficial effects of Pravastatin (±colestyramine/niacin) initiated immediately after a coronary event (the randomized lipid-coronary artery disease [L-CAD] study) [J].
Arntz, HR ;
Agrawal, R ;
Wunderlich, W ;
Schnitzer, L ;
Stern, R ;
Fischer, F ;
Schultheiss, HP .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (12) :1293-1298
[4]   Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study [J].
Aronow, HD ;
Topol, EJ ;
Roe, MT ;
Houghtaling, PL ;
Wolski, KE ;
Lincoff, AM ;
Harrington, RA ;
Califf, RM ;
Ohman, EM ;
Kleiman, NS ;
Keltai, M ;
Wilcox, RG ;
Vahanian, A ;
Armstrong, PW ;
Lauer, MS .
LANCET, 2001, 357 (9262) :1063-1068
[5]   Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention - The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study [J].
Athyros, VG ;
Papageorgiou, AA ;
Mercouris, BR ;
Athyrou, VV ;
Symeonidis, AN ;
Basayannis, EO ;
Demitriadis, DS ;
Kontopoulos, AG .
CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (04) :220-228
[6]   Myocardial infarction after noncardiac surgery [J].
Badner, NH ;
Knill, RL ;
Brown, JE ;
Novick, TV ;
Gelb, AW .
ANESTHESIOLOGY, 1998, 88 (03) :572-578
[7]  
BICCARD BM, 2005, ANAESTHESIA, V60
[8]   Effect of concomitant or very early statin administration on in-hospital mortality and reinfarction in patients with acute myocardial infarction [J].
Bybee, KA ;
Wright, RS ;
Williams, BA ;
Murphy, JG ;
Holmes, DR ;
Kopecky, SL .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (06) :771-+
[9]   Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[10]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3